Chapter 36 Taking Action

Early Detection

Detection of certain cancers at an early stage, along with timely treatment, permits less aggressive interventions, resulting in improved quality of life and survival.

There are two approaches to early detection – screening and early diagnosis. Screening aims to detect cancers or pre-cancerous lesions in otherwise healthy and asymptomatic individuals, whereas early diagnosis identifies symptomatic cancers at the earliest possible stage (Figure 36.1).

Figure 36.1

Screening versus early diagnosis according to symptom onset

Effective screening methods for early detection of cancer are available for cervical, colorectal, female breast, and lung cancers (Figure 36.2).

Figure 36.2

Common recommendations for screening of cancers of the cervix, breast, colorectum, and lung

Breast
  • Annual or biennial mammogram (preferred) 
  • Clinical breast exam (resource-limited setting for early diagnosis of symptomatic women)
  • 50 to 69 years, every 2 years
Cervix
  • Human papillomavirus (HPV) DNA-based test as primary test
  • Beginning at age 30, every 5 to 10 years for women with average risk
  • Beginning at age 25, every 3 to 5 years for women with human immunodeficiency viruses (HIV)
Colorectum
  • Stool-based tests (guaiac test or fecal immunochemical test (FIT)) every 1 or 2 years 
  • Lower endoscopy (colonoscopy every 10 years, flexible sigmoidoscopy every five years*)
  • 50 to 74 years, every 1-2 years
Lung
  • Low-dose computed tomography scan (low-dose CT scan or LDCT) for heavy smokers, current or those who have recently quit
  • 50 to 80 years, annually

Globally, only about 30% of women aged 30-49 had ever been screened for cervical cancer, ranging from 4% in Ethiopia to nearly 100% in Sweden, far below the WHO’s 70% target by 2030.

In addition, screening can prevent colorectal and cervical cancers through detection and removal of pre-cancerous lesions. However, implementing screening programs is complex and expensive. Decisions to introduce them involve balancing benefits against risks and limitations (Figure 36.3). A false positive test result can lead to significant physical, psychological, and financial harm.

Figure 36.3

Benefits, risks, and limitations of cancer screening

Many countries struggle with fiscal and infrastructural resources required to implement high-quality screening programs. This creates an uneven playing field where some populations benefit more than others. For example, there is a strong recommendation from the World Health Organization to start cervical cancer screening using human papillomavirus (HPV) detection tests at age 30 years for average risk women and at age 25 years for women living with human immunodeficiency virus. Yet, only 19 countries have rolled out HPV detection-based screening, all of which are high-income countries (Map 36.1).

“People just don’t know that you can have colon cancer and be completely asymptomatic and healthy.”

—Julie Gerberding Former Director, Centers for Disease Control and Prevention

Early diagnosis, the second approach to the early detection of cancer, is much less resource intensive than screening as it targets individuals with symptoms to reduce delays in diagnosis and improve cancer outcomes. Although it is less effective than screening, early diagnosis can be used for many common cancers, including breast cancer, particularly in low-resource settings where screening may not be feasible.

To implement both screening and early diagnosis programs, population awareness, trained health care professionals, prompt referral systems, and appropriate diagnostic and therapeutic infrastructure are essential.

Sources

Text


Maps

  • Map 36.1: Arbyn M., Currently applied policies for cervical cancer screening: a world survey. XXIV FIGO World Congress of Gynecology and Obstetrics, Paris (France), 9-12 October, 2023.

Figures